Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Other Non Operating Income (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Other Non Operating Income for 10 consecutive years, with $1.4 million as the latest value for Q1 2025.

  • Quarterly Other Non Operating Income changed N/A to $1.4 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.4 million for FY2025, N/A changed from the prior year.
  • Other Non Operating Income hit $1.4 million in Q1 2025 for Perspective Therapeutics, up from $2000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q1 2025 to a low of $2000.0 in Q2 2023.